Last reviewed · How we verify
FluMist live attenuated influenza vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
FluMist live attenuated influenza vaccine (FluMist live attenuated influenza vaccine) — Richard Zimmerman MD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| FluMist live attenuated influenza vaccine TARGET | FluMist live attenuated influenza vaccine | Richard Zimmerman MD | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- FluMist live attenuated influenza vaccine CI watch — RSS
- FluMist live attenuated influenza vaccine CI watch — Atom
- FluMist live attenuated influenza vaccine CI watch — JSON
- FluMist live attenuated influenza vaccine alone — RSS
Cite this brief
Drug Landscape (2026). FluMist live attenuated influenza vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/flumist-live-attenuated-influenza-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab